1. Home
  2. MRUS vs BDC Comparison

MRUS vs BDC Comparison

Compare MRUS & BDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • BDC
  • Stock Information
  • Founded
  • MRUS 2003
  • BDC 1902
  • Country
  • MRUS Netherlands
  • BDC United States
  • Employees
  • MRUS N/A
  • BDC N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • BDC Telecommunications Equipment
  • Sector
  • MRUS Health Care
  • BDC Telecommunications
  • Exchange
  • MRUS Nasdaq
  • BDC Nasdaq
  • Market Cap
  • MRUS 5.1B
  • BDC 5.2B
  • IPO Year
  • MRUS 2016
  • BDC 1993
  • Fundamental
  • Price
  • MRUS $94.81
  • BDC $119.37
  • Analyst Decision
  • MRUS Buy
  • BDC Strong Buy
  • Analyst Count
  • MRUS 18
  • BDC 5
  • Target Price
  • MRUS $93.72
  • BDC $135.20
  • AVG Volume (30 Days)
  • MRUS 2.6M
  • BDC 240.3K
  • Earning Date
  • MRUS 10-31-2025
  • BDC 10-30-2025
  • Dividend Yield
  • MRUS N/A
  • BDC 0.17%
  • EPS Growth
  • MRUS N/A
  • BDC 16.75
  • EPS
  • MRUS N/A
  • BDC 5.50
  • Revenue
  • MRUS $56,228,000.00
  • BDC $2,617,821,000.00
  • Revenue This Year
  • MRUS $51.77
  • BDC $9.55
  • Revenue Next Year
  • MRUS N/A
  • BDC $5.01
  • P/E Ratio
  • MRUS N/A
  • BDC $21.70
  • Revenue Growth
  • MRUS 59.77
  • BDC 12.93
  • 52 Week Low
  • MRUS $33.19
  • BDC $83.18
  • 52 Week High
  • MRUS $95.30
  • BDC $133.77
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 79.21
  • BDC 52.65
  • Support Level
  • MRUS $94.59
  • BDC $115.73
  • Resistance Level
  • MRUS $95.06
  • BDC $120.37
  • Average True Range (ATR)
  • MRUS 0.36
  • BDC 2.83
  • MACD
  • MRUS -1.00
  • BDC 0.94
  • Stochastic Oscillator
  • MRUS 47.87
  • BDC 76.90

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About BDC Belden Inc

Belden designs, manufactures, and markets advanced networking, connectivity, and cable solutions for industrial automation, smart buildings, and broadcast markets. Their portfolio includes cables, connectors, and networking equipment, enabling secure, reliable data transmission for applications in data centers, healthcare, education, hospitality, and more.

Share on Social Networks: